Domestic medical technology leader to invest in CCEDZ
Wang Jing (front left), deputy secretary of the Party working committee and director of the administrative committee of CCEDZ, and Liu Jun, chairman of Shanghai Hileap Medical Technology, sign a cooperation agreement. [Photo/WeChat account: ntjjkfq]
A signing ceremony on investment and cooperation between the Chongchuan Economic Development Zone, or CCEDZ – located in Chongchuan district in Nantong, East China's Jiangsu province – and Shanghai Hileap Medical Technology Co Ltd at Chongchuan district's government building on Oct 8.
Shanghai Hileap Medical Technology is a domestic leader in blood glucose detection. It has mastered the core technology to produce enzyme electrode biosensors, and boasts a number of intellectual property rights , including patents for the invention of biosensor blood glucose detectors and consumables.
LABQuan, one of Hileap's products, is a domestically leading point-of-care testing facility for blood glucose detection that is based on enzyme electrode biosensors and can be used for diagnosis.
The Nantong company will take advantage of the patented enzyme electrode biosensor technology to integrate upstream and downstream industry chain resources to boost the high-quality development of the blood glucose detection industry in the Yangtze River Delta region.
